
Please try another search
IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmune diseases. Its products include INB-400, which is in Phase 2 clinical trial to treat newly diagnosed glioblastoma (GBM); INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of GBM; and INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with hematologic malignancies undergoing hematopoietic stem cell transplantation. The company also develops INB-619, a gamma-delta TCE targeting CD19 for both oncology and autoimmune diseases; INB-300, a nsCAR-enabled DeltEx product candidates targeting difficult liquid tumors and extracranial solid tumors; and INB-500, an induced pluripotent stem cell derived gamma-delta T cells that are in preclinical phase for treatment of cancer. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020. IN8bio, Inc. was incorporated in 2016 and is based in New York, New York.
Name | Age | Since | Title |
---|---|---|---|
William Ho | 45 | 2015 | Co-Founder, President, CEO & Director |
Alan S. Roemer | 52 | 2020 | Independent Chairman of the Board |
Dieter Kabelitz | - | - | Member of Scientific Advisory board |
Jeremy R. Graff | 55 | 2023 | Independent Director |
Marcela V. Maus | 49 | - | Member of Scientific Advisory Board |
Peter C. Brandt | 68 | 2019 | Independent Director |
Emily Wang Fairbairn | 62 | 2021 | Independent Director |
Siraj M. Ali | - | - | Member of Scientific Advisory Board |
Bianca Santomasso | - | - | Member of Scientific Advisory Board |
Bruce L. Levine | - | - | Member of Scientific Advisory Board |
Michael R. Bishop | - | 2022 | Member of Scientific Advisory Board |
Corinne D. Epperly | 46 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review